Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3

Class:IdLiteratureReference:4084767
_displayNameIntegrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3
_timestamp2013-07-31 15:04:40
author[Person:4084773] Borza, Corina M
[Person:1181019] Pozzi, A
[Person:4084739] Borza, Dorin-Bogdan
[Person:2559647] Pedchenko, Vadim
[Person:4084791] Hellmark, Thomas
[Person:2559609] Hudson, Billy G
[Person:4084770] Zent, Roy
created[InstanceEdit:4084738] Jupe, S, 2013-07-31
journalJ. Biol. Chem.
pages20932-9
pubMedIdentifier16731529
titleIntegrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3
volume281
year2006
(literatureReference)[Summation:2327767] The widely-expressed collagen receptors integrin alpha2beta1...
[Summation:4085091] Tumstatin, the non collagenous C-teminal domain of alpha-3(I...
[Reaction:4085083] Tumstatin binds integrin alphaVbeta 3, alpha3beta1 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3 (4084767)